Association between ERCC5 Gene (SNP: rs2296147 T>C) and the Risk of Breast Cancer in Northwest of Iran

Sadat AbbasAbad, Rana; Ghaffarian, Sara

doi:10.22034/11.4.12

Association between ERCC5 Gene (SNP: rs2296147 T>C) and the Risk of Breast Cancer in Northwest of Iran

Authors

Rana Sadat abbasAbad ¹

Sara Ghaffarian ²

¹ MSc graduate, Department of Cellular and Molecular Biology, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran

² Assistant Professor, Department of Cellular and Molecular Biology, Faculty of Sciences, Azarbaijan Shahid Madani University, Tabriz, Iran

https://doi.org/10.22034/11.4.12

Abstract

ERCC5 gene, is a key components of NER pathway and encodes a key endonuclease. In this study, we analyzed the association between rs2296147 T>C polymorphism of ERCC5 gene with the risk of breast cancer in a case-control study with statistical population consisting of 100 patients and 100 healthy controls by Tetra-ARMS PCR. Statistical analysis was performed using javastat online statistics package and SPSS V.26. The frequency of CC, CT, and TT genotypes in the case group, were 11.46%, 58.33%, and 30.21%, respectively and they were 22%, 44%, and 34% for the control group. Statistical analysis showed a significant association between CC (p-value=0.049) (OR=0.459, CI 95%=0.209-1.007) and CT genotype (p-value=0.045) (OR=1.782, CI 95%=1.012-3.139) with breast cancer risk. Also, C and T alleles frequency in the case group, were 40.62 % and 59.37% and those in the control group were 44 % and 56 % respectively. There was not any significant association between T (p-value=0.499) and C (p-value=0.499) alleles frequency and breast cancer risk in Northwestern Iran. Also, there was no significant association between this SNP frequency and patient’s pathological traits. In conclusion, our study indicated that ERCC5 rs2094258 polymorphism may contribute to the risk of breast cancer in northwestern of Iran.

Keywords

Case-Control study

Nucleotide excision Repair

Pathological traits

Single Nucleotide Polymorphism

ERCC5 gene

Braunwald, S.A., Fauci, L.D., Kasper, L.S., Hauser, L.D., Longo, L. & Jameson, J. 2001. Harrison’s principles of internal medicine. 15th edition, McGraw-Hill publications, New York, United states, pp. 1187. ISBN 13: 9780079136862
Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M. & Werner, T. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics, vol. 21, pp. 2933-2942, 2005. doi: 10.1093/bioinformatics/bti473
Ding, P.D., He, X.F. & Zhang, Y. 2011. Association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case–control studies ", BreastCancer Research and Treatment, vol. 129, pp. 203-209. doi: 10.1007/s10549-011-1447-9
Hohl, M., Dunand_Sauthier, I.L., Staresincic, L., Jaquier-Gubler, P., Thorel, F., Mauro, M., Clarkson, S.G. & Scharer, O.O. 2007. Domain swapping between FEN-1 and XPG defines regions in XPG the mediate nucleotide excision repair activity and substrate specificity. Nucleic acids research 135: 3053-3063. doi:10.1093/nar/gkm092
Huang, S., He, A., Xie, N., Xu, D., Chen, Q. & Qi, S. 2018. Associations between seven polymorphisms in ERCC5 and gastric cancer susceptibility: a systematic review and meta-analysis. International Journal of Clinical and Experimental Medicine 11: 3043-3050. ISSN:1940-5901/IJCEM0063709.
Lan, X., Li, Y., Wu, Y., Li, X. & Xu, L. 2022. The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese. Journal of Cancer 13: 517-526. doi: 10.7150/jca.59277
Liu, Y., Hu, Y., Zhang, M., Jiang, R. & Liang, G. 2018. Polymorphism in ERCC2 and ERCC5 and risk of prostate cancer, A meta- analysis and systemic review. Journal of Cancer 9: 2786-2794. 2018. doi:10.7150/jca.25356
Malik, S.S., Sumaira Mubarik, S. & Masood, N. 2018. Muhammad Tahir Khadim. An insight into clinical outcome of XPG polymorphisms in breast cancer. Molecular Biology Reports 45: 2369-2375. doi:10.1007/s11033-018-4401-7
Na, N., Dun, E., Ren, L., & Li, G. 2015. Association between ERCC5 gene polymorphisms and breast cancer risk. International Journal of Clinical and Experimental Pathology 8: 3192-3197. PMID: 26045839; PMCID: PMC4440148.
Pittman A.M., Naranjo, S., Jalava, E., Twiss, P., Ma, Y., Olver, B. & Houlston, R.S. 2010. Allelic variation at the 8q23. 3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H. PLoS Genetics 6: 8600-8606. doi: 10.1371/journal.pgen.1001126
Rudolph, A., Chang-Claude, J. & Schmidt, M.K. 2016. Gene-environment interaction and risk of breast cancer. British journal of cancer 114: 125-133. doi: 10.1038/bjc.2015.439
Scherly, D., Nouspikel, T., Corlet, J., Ucla, C. & Bairoch A. 1993. Complementation of the DNA repairdefect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2. Nature 363: 182-185. doi: 10.1038/363182a0
Suguna. S., Nandal, D.H. & Kamble, S., 2014. Genomic DNA isolation from human whole blood samples by non-enzymatic salting out method. International Journal of Pharmacy and Pharmaceutical Sciences 6: 198-199. https://innovareacademics.in/journal/ijpps/Vol6Issue6/9478.pdf
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. & Bray, F. 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. A Cancer Journal for Clinician 71(3): 209-249. doi:10.3322/caac.21660
Siegel, L.R., Miller D.K. & Jemal A. 2018. Cancer statistics. Cancer Journal for clinicians, 68: 7- 30. doi:10.3322/caac.21442
Takahashi, E.I., Shiomi, N. & Shiomi, T. 1992. Precise localization of the excision repair gene, ERCC5, to human chromosome 13q32. 3‐q33. 1 by direct R‐banding fluorescence in situ hybridization," Japanese Journal of Cancer Research, vol. 83, pp. 1117-1119. doi: 10.1111/j.1349-7006.1992.tb02731.x
Tutt, A. & Ashworth A. 2002. The relationship between the rols of BRCA genes in DNA repair and cancer predisposition. Trends in molecular medicine 8: 571-576. doi: 10.1016/s1471-4914(02)02434-6
Wakasugi M., Reardon T.J. & Sancar A.,” The Non- catalytic function of XPG protein during dual incision in human nucleotide excision repair”, Journal of Biological chemistry, vol. 272, pp. 16039- 16034, 1997. doi:10.1074/jbc.272.25.16030
Wood, D.R. 1997. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81: 39- 44. doi:10.1016/s0300-9084(99)80036-4

Yuan, P., Liu, D. &Deng, N. 2014. Identification of differently expressed genes with specific SNP loci for breast cancer by the integration of SNP and gene expression profiling analyses. Pathology & Oncology Research 21: 469-475. doi: 10.1007/s12253-014-9851-1
Zhang, X., Crawford, E.L., Blomquist, T.M., Khuder, S.A., Yeo, J., Levin, A.M. & Willey J.C. 2016. Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells. Physiological genomics 48: 537- 543. doi: 10.1152/physiolgenomics.00021
Zuo, C., Lv, X., Liu, T., Yang, L., Yang, Z., Yu, C. & Chen H. 2022. Polymorphism in ERCC4 and ERCC5 and risk of cancer: systematic research synopsis, meta-analysis, and epidemiological evidence. Frontiers in oncology 11:12:951193. doi: 10.3389/fonc.2022.951193